Rentokil Initial plc Sponsored ADR RTO 深 沪
等待开盘 10-13 09:30:00 美东时间
20.26
+0.020
+0.10%
华盛通- 最 高20.45
- 今 开20.38
- 成交量 132.14万股
- 最 低 20.24
- 昨 收 20.24
- 总市值 102.36亿
- 52周最高 34.4858
- 市盈率 静 21.80
- 换手率 0.26%
- 52周最低 19.495
- 委 比 66.67%
- 总股本 5.05亿
- 历史最高 39.8285
- 量 比 0.70
- 振 幅 1.04%
- 历史最低 18.8928
- 每 手 1
- 风险率 3.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股盘前 | Summit Therapeutics暴升21.12%，如瑞迪博士上升4.32%
Summit Therapeutics暴升21.12%；如瑞迪博士上升4.32%；金田上升3.10%
09-29 16:11
Top 3 Industrials Stocks You'll Regret Missing This Quarter
The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give...
08-20 18:23
Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Thursday. Shares of Meta Platforms Inc (NASDAQ:META) fell sharply in pre-market trading after the company posted mixed financial results for the second quarter. Meta reported second-quarter revenue of $60.80 bil...
07-30 20:03
Rentokil Initial H1 EPS $0.14 Up From $0.07 YoY, Sales $3.589B Beat $3.554B Estimate
Rentokil Initial (NYSE:RTO) reported quarterly earnings of $0.14 per share. This is a 100 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $3.589 billion which beat the analyst consensus estimate of $3.554 billion by 0.98 perce...
07-30 18:38
UBS Upgrades Rentokil Initial to Buy
UBS analyst Nicole Manion upgrades Rentokil Initial (NYSE:RTO) from Neutral to Buy.
03-12 22:15
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
Oppenheimer Maintains Outperform on Rentokil Initial, Raises Price Target to $35
Oppenheimer analyst Ian Zaffino maintains Rentokil Initial (NYSE:RTO) with a Outperform and raises the price target from $30 to $35.
03-10 22:20
